FHL-501

N/A

Report date: 2023/09/04 17:40:10
NME

Base Information

Drug NameFHL-501
Drug Alias NameFHL-501
ClassificationOther
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesForest Hills Lab
China Registration ClassN/A

Develop Information

Active CompaniesForest Hills Lab
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A